Owens David

Average Profitability
<0.0001%
Insider Buys Quantity
10
Insider Buys Sum
$27,674.49
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Owens David

According to the SEC Form 4 filings, Owens David, being in a position of

  1. Chief Medical Officer at Nexalin Technology, Inc.,
    оver the last 12 months, has bought 14619 shares for $27,674, and sold 0 shares,
    over all time since 2024-06-10, has bought 14619 shares for $27,674, and sold 0 shares.

The largest purchase of all time was on 2025-02-04 and amounted to 1000 shares of Nexalin Technology, Inc. for $2,980.

Biography of Owens David

No biography is available at this moment.

2025-02-04PurchaseNexalin Technology, Inc.
NXL
Chief Medical Officer
1,000
0.0076%
$2.98$2,980+12.38%
2025-02-04PurchaseNexalin Technology, Inc.
NXL
Chief Medical Officer
2,000
0.0154%
$3.04$6,080+12.38%
2025-01-28PurchaseNexalin Technology, Inc.
NXL
Chief Medical Officer
1,500
0.0126%
$2.70$4,050+21.21%
2025-01-23PurchaseNexalin Technology, Inc.
NXL
Chief Medical Officer
1,000
0.008%
$2.70$2,700+16.15%
2025-01-13PurchaseNexalin Technology, Inc.
NXL
Chief Medical Officer
2,000
0.0156%
$2.50$5,000+18.33%
2024-10-28PurchaseNexalin Technology, Inc.
NXL
Chief Medical Officer
500
0.0058%
$2.19$1,0950%
2024-08-13PurchaseNexalin Technology, Inc.
NXL
Chief Medical Officer
1,000
0.0097%
$0.95$9500%
2024-06-28PurchaseNexalin Technology, Inc.
NXL
Chief Medical Officer
1,000
0.0084%
$1.75$1,7500%
2024-06-18PurchaseNexalin Technology, Inc.
NXL
Chief Medical Officer
1,619
0.0056%
$0.71$1,149+119.23%
2024-06-10PurchaseNexalin Technology, Inc.
NXL
Chief Medical Officer
3,000
0.0093%
$0.64$1,920+124.24%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.